KPK. V. Pavlenko

K. V. Pavlenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


K. V. Pavlenko has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • NUTRITION METHOD OF ACTIVATING OSTEOGENESIS IN THE ORGANISM OF FARM ANIMALS AND POULTRY

    by А. Levitsky, B. Iegorov, А. Makarynska, А. Lapinska, K. Pavlenko, O. Voloshuk

    Minerals take part in all metabolic processes of the body of farm animals and poultry, are catalysts of metabolism; enzyme and hormonal systems, take part in the implementation of the immune response, development and integrity of tissues and bones, protection from oxidative stress, growth and division of cells, plumage, appetite formation, etc. The efficiency of mineral metabolism depends on the productivity of farm animals and poultry, the quality and safety of livestock and poultry products, profitability and profitability of industries. The problem of ensuring bone mineralization for young modern highly productive animals and poultry, providing calcium for laying hens, dairy cows, in which the course of metabolic processes, the functions of individual systems and organs are carried out on the border of norm and pathology, is urgent. It is substantiated that due to a number of problems, the correction of mineral metabolism during the maintenance process is ineffective, the development of nutritional methods for managing mineralization processes in the body of farm animals and poultry is promising. To maintain the metabolism of macroelements, osteobiotic components are appropriate, since the most frequent problem of mineral supply is not a deficiency in feed, but the problem of metabolism and endogenous losses in the body. To activate osteogenesis, the choice of isoflavones is justified, since the wide spectrum of biological action of polyphenols allows for a systemic corrective effect on organs and systems, significantly increasing the nonspecific resistance of the body to endo- and exogenous factors. Using the developed technology, a feed additive of soy isoflavones EKSO was obtained, its effect on the main indicators of mineral metabolism in the body of laboratory animals was determined, and the prospects for its use as a component of compound feed products to ensure osteobiotic action were outlined. It has been established that the chemical composition of EXO is represented by a wide range of water-soluble substances: peptides, amino acids (32-38%), sugars 42-46% (raffinose and stachyose, etc.), vitamins, macro- and microelements, isoflavones genistein and daidzein. A significant number of proteolysis inhibitors in the preparation, which have anti-inflammatory properties, prebiotics (raffinose and stachyose), which eliminate the phenomenon of dysbiosis and allow using the potential of normobiota to enhance osteobiotic action. In vivo it was established: the introduction of the feed additive of soy isoflavones EXSO into the body increases the activity of alkaline phosphatase (a biochemical marker of osteoblasts) in the blood serum: starting from the 8th day of use, at a dose of 300 mg/g, as well as from the 24th day at a dose of 150 mg/kg, and by the end of the observation, the activity level is significantly higher than the corresponding indicators in the control group. The introduction of EXSO reduces the calcium content in the blood on the 14th day at a dose of 300 mg/kg and on the 34th day at a dose of 150 mg/kg, which indicates an intensive course of mineralization processes in the body. Daily administration of EXSO significantly shortened the period of bone densification: at a dose of 150 mg/kg - 30 days earlier, and 300 mg/kg - 40 days earlier than in the control group. It is advisable to use the feed preparation of soy isoflavones EKSO in the production of compound feed products, not increasing the calcium content in the feed, but normalizing metabolic processes in the body, which will allow avoiding diseases and pathologies caused by excessive intake the calcium.

  • Open Access

    Gluten free fermented amaranth product for celiacs

    by A. P. Levytsky, В. О. Малиновський, Y. S. Yuzkiv, I. O. Selivanska, A. P. Lapinska, K. V. Pavlenko, Я. С. Юзьків, І. О. Селіванська

    Celiac disease, one of the clinical forms of food allergies, is caused by intolerance to the protein product gluten, which is found in large quantities in wheat, rye, barley and corn flour. Patients with celiac disease need to consume gluten‑free protein products. One of these products can be amaranth flour. Objective — to determine the protein spectrum of amaranth flour and the dietary supplement MAF (fermented amaranth flour) using the classical Osborn method. Materials and methods. The protein spectrum was determined by the Osborn method by direct extraction with the following solvents: distilled water, 4% solution NaCl, 60% isopropanol, 1% NaOH solution, 20% trichloroacetic acid (TCA) solution. The protein content was determined by the Lowry method. Limited proteolysis of amaranth proteins was conducted with chymosin (ph 3.5). The content of oligopeptides was determined by the protein content in the supernatant after extraction with TCA. The content of albumins was identified by the protein content in the supernatant after extraction with water (minus the content of oligopeptides). The content of globulins was assessed by the protein content in the supernatant after extraction with 4% NaCl solution (minus the protein content in the supernatant after extraction with water). The content of the alkali‑soluble (gluten‑like) fraction was defined by the protein content in the supernatant after extraction with solution NaOH (minus the protein content after extraction with NaCl solution). Results. It was established that the content of albumins and globulins in amaranth flour is 25—30% of the total protein level, the prolamin (alcohol‑soluble) fraction is less than 3% and the alkali‑soluble (glutelin) fraction is more than 65%. After limited proteolysis, the content of albumins and globulins was more than 70%, the oligopeptide fraction increased significantly (up to 20%) and the «glutelin» fraction was almost absent. Conclusions. After limited proteolysis of the amaranth flour, the content of the alkali‑soluble fraction was significantly reduced, but the content of albumins, globulins and oligopeptides increased. It is recommended that patients with celiac disease consume the gluten‑free protein product MAF.